| Literature DB >> 32347684 |
Roberta Rudà1, Filippo F Angileri2, Tamara Ius3, Antonio Silvani4, Silvio Sarubbo5, Alessandra Solari6, Antonella Castellano7, Andrea Falini7, Bianca Pollo8, Marialaura Del Basso De Caro9, Costanza Papagno10,11, Giuseppe Minniti12, Ugo De Paula13, Pierina Navarria14, Antonio Nicolato15, Andrea Salmaggi16, Andrea Pace17, Alessandra Fabi18, Maria Caffo19, Giuseppe Lombardi20, Carmine M Carapella17, Giannantonio Spena21, Maurizio Iacoangeli22, Marco Fontanella23, Antonino F Germanò19, Alessandro Olivi24, Lorenzo Bello25, Vincenzo Esposito26,27, Miran Skrap3, Riccardo Soffietti1.
Abstract
In 2018, the SINch (Italian Society of Neurosurgery) Neuro-Oncology Section, AINO (Italian Association of Neuro-Oncology) and SIN (Italian Association of Neurology) Neuro-Oncology Section formed a collaborative Task Force to look at the diagnosis and treatment of low-grade gliomas (LGGs). The Task Force included neurologists, neurosurgeons, neuro-oncologists, pathologists, radiologists, radiation oncologists, medical oncologists, a neuropsychologist and a methodologist. For operational purposes, the Task Force was divided into five Working Groups: diagnosis, surgical treatment, adjuvant treatments, supportive therapies, and follow-up. The resulting guidance document is based on the available evidence and provides recommendations on diagnosis and treatment of LGG patients, considering all aspects of patient care along their disease trajectory.Entities:
Mesh：
Year: 2020 PMID： 32347684 DOI： 10.23736/S0390-5616.20.04982-6
Source DB: PubMed Journal: J Neurosurg Sci ISSN： 0390-5616 Impact factor: 2.279